AstraZeneca is in advanced talks with Summit Therapeutics over a potential $15 billion deal for the lung cancer drug ivonescimab.
AstraZeneca In $15B Talks For Drug That Could Upend Lung Cancer Treatment
Where Today's News Shapes Tomorrow
February 20, 2026
Headlines
